Literature DB >> 35358392

Development of Novel 191Pt-Labeled Hoechst33258: 191Pt Is More Suitable than 111In for Targeting DNA.

Honoka Obata1,2,3, Atsushi B Tsuji2, Katsushi Kumata1, Hitomi Sudo2, Katsuyuki Minegishi1, Kotaro Nagatsu1, Hideo Takakura3, Mikako Ogawa3, Akihiro Kurimasa4, Ming-Rong Zhang1.   

Abstract

This study aims to establish new labeling methods for no-carrier-added radio-Pt (191Pt) and to evaluate the in vitro properties of 191Pt-labeled agents compared with those of agents labeled with the common emitter 111In. 191Pt was complexed with the DNA-targeting dye Hoechst33258 via diethylenetriaminepentaacetic acid (DTPA) or the sulfur-containing amino acid cysteine (Cys). The intranuclear fractions of 191Pt- and 111In-labeled Hoechst33258 were comparable, indicating that the labeling for 191Pt via DTPA or Cys and the labeling for 111In via DTPA worked equally well. 191Pt showed a DNA-binding/cellular uptake ratio of more than 1 order of magnitude greater than that of 111In. [191Pt]Pt-Hoechst33258 labeled via Cys showed a higher cellular uptake than that labeled via DTPA, resulting in a very high DNA-binding fraction of [191Pt]Pt-Cys-Hoechst33258 and extensive DNA damage. Our labeling methods of radio-Pt, especially via Cys, promote the development of radio-Pt-based agents for use in Auger electron therapy targeting DNA.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35358392      PMCID: PMC9014856          DOI: 10.1021/acs.jmedchem.1c02209

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   8.039


  38 in total

Review 1.  Radiation spectra for Auger-electron emitting radionuclides: report No. 2 of AAPM Nuclear Medicine Task Group No. 6.

Authors:  R W Howell
Journal:  Med Phys       Date:  1992 Nov-Dec       Impact factor: 4.071

2.  Nuclear Targeting with an Auger Electron Emitter Potentiates the Action of a Widely Used Antineoplastic Drug.

Authors:  Sebastian Imstepf; Vanessa Pierroz; Paula Raposinho; Matthias Bauwens; Michael Felber; Thomas Fox; Adam B Shapiro; Robert Freudenberg; Célia Fernandes; Sofia Gama; Gilles Gasser; Felix Motthagy; Isabel R Santos; Roger Alberto
Journal:  Bioconjug Chem       Date:  2015-10-29       Impact factor: 4.774

Review 3.  Radiobiologic principles in radionuclide therapy.

Authors:  Amin I Kassis; S James Adelstein
Journal:  J Nucl Med       Date:  2005-01       Impact factor: 10.057

4.  Cisplatin interaction with cysteine and methionine, a theoretical DFT study.

Authors:  Tomás Zimmermann; Michal Zeizinger; Jaroslav V Burda
Journal:  J Inorg Biochem       Date:  2005-09-23       Impact factor: 4.155

5.  Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.

Authors:  N Sato; H Kobayashi; T Saga; Y Nakamoto; T Ishimori; K Togashi; Y Fujibayashi; J Konishi; M W Brechbiel
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

6.  Radiotoxicity of 125I in mammalian cells.

Authors:  A I Kassis; F Fayad; B M Kinsey; K S Sastry; R A Taube; S J Adelstein
Journal:  Radiat Res       Date:  1987-08       Impact factor: 2.841

Review 7.  Nuclear data for production and medical application of radionuclides: Present status and future needs.

Authors:  Syed M Qaim
Journal:  Nucl Med Biol       Date:  2016-09-02       Impact factor: 2.408

8.  Synthesis of no-carrier-added [188, 189, 191Pt]cisplatin from a cyclotron produced 188, 189, 191PtCl42- complex.

Authors:  Honoka Obata; Katsuyuki Minegishi; Kotaro Nagatsu; Mikako Ogawa; Ming-Rong Zhang
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

Review 9.  Biological consequences of radiation-induced DNA damage: relevance to radiotherapy.

Authors:  M E Lomax; L K Folkes; P O'Neill
Journal:  Clin Oncol (R Coll Radiol)       Date:  2013-07-10       Impact factor: 4.126

10.  Radiotoxicity of platinum-195m-labeled trans-platinum (II) in mammalian cells.

Authors:  R W Howell; A I Kassis; S J Adelstein; D V Rao; H A Wright; R N Hamm; J E Turner; K S Sastry
Journal:  Radiat Res       Date:  1994-10       Impact factor: 3.372

View more
  1 in total

1.  Searching for a Paradigm Shift in Auger-Electron Cancer Therapy with Tumor-Specific Radiopeptides Targeting the Mitochondria and/or the Cell Nucleus.

Authors:  Célia Fernandes; Elisa Palma; Francisco Silva; Ana Belchior; Catarina I G Pinto; Joana F Guerreiro; Hugo M Botelho; Filipa Mendes; Paula Raposinho; António Paulo
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.